On Aug. 23, Covington-based Omnicare (NYSE: OCR) offered to purchase all of the outstanding shares of PharMerica (NYSE: PMC) for $15 per share in cash. Officials at Louisville-based PharMerica have repeatedly rejected the offer, citing concerns that the bid undervalues the company and that an acquisition would face steep regulatory hurdles.
?The PharMerica board of directors is unanimous in its well-informed belief that Omnicare?s offer is lacking in both price and certainty of closing,? Gregory Weishar, PharMerica?s CEO, said in a news release this week...
hollywood news and gossip recent news articles celebrity deaths rte news now
No comments:
Post a Comment